Evidence browser

Musculoskeletal Pain in Individuals With Inflammatory Bowel Disease Reflects Three Distinct Profiles.

Falling, Carrie, Stebbings, Simon, Baxter, George D et al.·The Clinical journal of pain·2019

Most people with inflammatory bowel disease (IBD) experience muscle and joint pain, but the pain works differently in different people. This study found three distinct groups: one with mixed types of pain, one with pain driven by nervous system sensitivity, and one with pain in specific areas that improves when the IBD is under control. The group with nervous system-driven pain had higher rates of depression, anxiety, and chronic fatigue syndrome.

Pain and Sensitization

E2 ModerateCohortPEM not requiredLongitudinal

Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia.

Hyland, Michael E, Lanario, Joseph W, Wei, Yinghui et al.·Immunity, inflammation and disease·2019

This study found that people with severe asthma report many symptoms beyond breathing problems—such as fatigue, pain, and digestive issues—that are very similar to symptoms seen in fibromyalgia and chronic fatigue syndrome. The researchers compared symptom patterns between asthma patients and people with various functional disorders, finding that asthma and fibromyalgia symptoms were 75% similar in type and pattern. This suggests these conditions may share common underlying mechanisms related to how the body's systems interact.

Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study.

Tsai, Shin-Yi, Chen, Hsuan-Ju, Lio, Chon-Fu et al.·Journal of translational medicine·2019

This study found that people with inflammatory bowel disease (IBD) are more than twice as likely to develop ME/CFS compared to people without IBD. The researchers looked at medical records from Taiwan and followed patients over time to see who developed ME/CFS. The increased risk was especially high in men and older adults with IBD who didn't have other chronic conditions.

Cytokine profiles in patients with Q fever fatigue syndrome.

Raijmakers, Ruud P H, Koeken, Valerie A C M, Jansen, Anne F M et al.·The Journal of infection·2019

This study looked at inflammatory markers in people who developed prolonged fatigue after Q fever infection. Researchers compared blood samples from patients with Q fever fatigue syndrome, chronic fatigue syndrome patients, people who had Q fever but recovered, and healthy controls. They found that Q fever fatigue syndrome patients had higher levels of specific inflammation proteins, suggesting chronic inflammation may be driving their ongoing fatigue.

E2 ModerateCohortPEM unclearObservational

Open Trial of Vitamin B12 Nasal Drops in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison of Responders and Non-Responders.

van Campen, C Linda Mc, Riepma, Klaas, Visser, Frans C·Frontiers in pharmacology·2019

This study tested whether vitamin B12 nasal drops could help people with ME/CFS. Fifty-one patients used the nasal drops for 3 months, and about two-thirds reported feeling better. Those who improved showed increases in their activity levels, better fatigue scores, and significantly higher vitamin B12 levels in their blood. The nasal drops appear to be a practical alternative to vitamin B12 injections for some patients.

E2 ModerateBehavioralPEM not requiredCross-Sectional

[Fatigue among working and non-working students: a sociological analysis of the environmental determinants of its level].

Kutyło, Łukasz, Łaska-Formejster, Alicja Barbara, Ober-Domagalska, Barbara·Medycyna pracy·2019

This study compared fatigue levels in 298 college students, some who worked while studying and some who did not. Interestingly, non-working students reported significantly more fatigue than working students. The researchers found that students who were less satisfied with their classes, teachers, or peer relationships tended to feel more tired.

E2 ModerateCohortPEM not requiredCase-Control

MicroRNAs as Biomarkers of Pain Intensity in Patients With Chronic Fatigue Syndrome.

Al-Rawaf, Hadeel A, Alghadir, Ahmad H, Gabr, Sami A·Pain practice : the official journal of World Institute of Pain·2019

This study looked at tiny molecules called microRNAs in the blood of adolescents with ME/CFS to see if they could help explain why these patients experience pain. Researchers found that five specific microRNAs were lower in ME/CFS patients compared to healthy teens, and these changes were linked to higher levels of inflammatory chemicals that are known to cause pain. Interestingly, girls with ME/CFS had even lower microRNA levels and higher inflammation markers than boys with the condition.

BiomarkersImmune System

E2 ModerateCohortPEM not requiredCase-Control

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

Raijmakers, Ruud P H, Jansen, Anne F M, Keijmel, Stephan P et al.·Journal of translational medicine·2019

This study looked at a specific type of protein fragment called humanin that is made inside cells' energy factories (mitochondria). Researchers found that people with ME/CFS and Q fever fatigue syndrome had lower levels of this protein compared to healthy people. The findings suggest that problems with how these protein fragments are made may be involved in causing fatigue in these conditions.

E2 ModerateBehavioralPEM not requiredLongitudinal

A logistic regression analysis of risk factors in ME/CFS pathogenesis.

Lacerda, Eliana M, Geraghty, Keith, Kingdon, Caroline C et al.·BMC neurology·2019

This study looked at what factors might increase someone's risk of developing ME/CFS by comparing 269 people with ME/CFS to people with multiple sclerosis and healthy controls. Researchers found that having frequent colds or infections before illness onset, being single, having lower income, and having a family history of anxiety or neurological illness were linked to higher ME/CFS risk. The study suggests that infections may play an important role in how ME/CFS develops, which differs from multiple sclerosis.

Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome.

Janse, Anthonie, Bleijenberg, Gijs, Knoop, Hans·Journal of psychosomatic research·2019

This study followed 511 ME/CFS patients for up to 10 years after they completed cognitive behavioral therapy (CBT) to see which factors predicted who would recover better long-term. Researchers found that patients who started with less severe fatigue, had symptoms for a shorter time before treatment, and felt more in control of their fatigue tended to have better outcomes years later. The study suggests that maximizing improvements during treatment and addressing pain may be important for lasting recovery.

Interventions

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Chu, Lily, Valencia, Ian J, Garvert, Donn W et al.·Frontiers in pediatrics·2019

This study surveyed 150 people with ME/CFS about how their illness started and changed over time. Most people reported their ME/CFS began after an infection, stress, or chemical exposure. While some symptoms like fatigue and flu-like feelings improved slightly over time, others like brain fog stayed about the same or got worse, and nearly half of participants couldn't work by the time of the study.

Post-Exertional Malaise

Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Blomberg, Jonas, Rizwan, Muhammad, Böhlin-Wiener, Agnes et al.·Frontiers in immunology·2019

This study looked for evidence that common viruses called herpesviruses might be reactivated or causing problems in ME/CFS patients. Researchers tested blood samples from ME/CFS patients and healthy people to measure immune responses (antibodies) against several herpesviruses. While the overall antibody levels were similar between the two groups, the study found subtle differences in how ME/CFS patients' immune systems reacted to a few specific herpesvirus proteins.

Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome.

Sweetman, Eiren, Ryan, Margaret, Edgar, Christina et al.·International journal of immunopathology and pharmacology·2019

Researchers studied blood immune cells from 10 ME/CFS patients and 10 healthy people to understand what's different at the genetic level. They found that several genes related to inflammation were more active in ME/CFS patients, and genes related to energy production and circadian rhythms (your body's internal clock) showed abnormal patterns. These findings suggest ME/CFS involves multiple biological systems working incorrectly at the same time.

E2 ModerateCohortPEM not requiredObservational

Epidemiology of paediatric chronic fatigue syndrome in Australia.

Knight, Sarah, Elders, Shane, Rodda, Jill et al.·Archives of disease in childhood·2019

This study looked at how many Australian children develop ME/CFS and what their experiences are like. Researchers tracked newly diagnosed cases over one year and found that the condition is quite rare in children under 10, but becomes more common in teenagers. Interestingly, the rates were very different depending on where children lived in Australia, suggesting some areas may be better at recognizing and diagnosing the condition than others.

Diagnostics

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Cliff, Jacqueline M, King, Elizabeth C, Lee, Ji-Sook et al.·Frontiers in immunology·2019

This study examined the immune system of ME/CFS patients by testing their blood for signs of infection and measuring different types of immune cells. Researchers compared 251 ME/CFS patients (including 54 with severe ME/CFS) to healthy people and multiple sclerosis patients. They found that ME/CFS patients had unusual patterns in their T cells—a type of immune cell—but not in natural killer cells, contrary to what some earlier studies suggested.

E2 ModerateCohortPEM not requiredObservational

Decreased Expression of the CD57 Molecule in T Lymphocytes of Patients with Chronic Fatigue Syndrome.

Espinosa, P, Urra, J M·Molecular neurobiology·2019

Researchers measured levels of a protein called CD57 on immune cells in ME/CFS patients and compared them to healthy people. They found that ME/CFS patients had significantly lower amounts of CD57 on their T cells (a type of white blood cell). This difference was large enough that measuring CD57 levels could potentially help doctors diagnose ME/CFS.

BiomarkersImmune System

E2 ModerateCohortPEM requiredCross-Sectional

Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity.

Lidbury, Brett A, Kita, Badia, Richardson, Alice M et al.·Diagnostics (Basel, Switzerland)·2019

This study looked for blood test markers that could help diagnose ME/CFS and measure how severe someone's illness is. Researchers tested a protein called activin B along with routine blood work from pathology labs in people with ME/CFS and healthy controls. They used a computer learning method to see which combinations of blood markers worked best for identifying ME/CFS and predicting symptom severity.

Biomarkers

Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study.

Kristiansen, Miriam Skjerven, Stabursvik, Julie, O'Leary, Elise Catriona et al.·Brain, behavior, and immunity·2019

This study looked at adolescents who had Epstein-Barr virus (EBV) infection and tracked whether they developed chronic fatigue 6 months later. Researchers found that those with ongoing fatigue had more symptoms overall, but blood tests and heart-monitoring showed only small differences compared to those who recovered—mainly slightly higher inflammation markers and changes in nervous system activity. The study suggests that post-EBV fatigue in teenagers involves subtle changes in the body's stress and immune systems, even though the virus itself had cleared.